Ecnoglutide, a novel once-weekly injection for type 2 diabetes management, works as well as dulaglutide (a commonly ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

Trulicity (dulaglutide), a once-weekly subcutaneous injection, has been approved by the U.S. Food and Drug Administration to improve glycemic control in adults with type 2 diabetes along with diet ...

Topline data were announced from a head-to-head phase 3 trial evaluating tirzepatide vs dulaglutide in adults with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease ...

Dulaglutide injections are still in shortage, though manufacturers report all presentations available. Liraglutide injections also remain in shortage with two presentations available and three in ...

Results Interviews were completed by 201 participants (52.7% male; mean age = 58.7). Preferences between treatment processes varied widely. Mean utilities were 0.890 for simple oral, 0.880 for oral ...